FIGR vs REGN · P/E 36, rev $156.4M vs P/E 14, rev $14.34B
Figure Technology Solutions, Inc. Class A Common Stock (FIGR) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Figure Technology Solutions, Inc. Class A Common Stock (FIGR) is a capital markets company listed on NASDAQ.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported FIGR revenue for 2025-09-30 was $156.4M. Net income was $89.8M. Revenue was up 54.8% from 2024-09-30 to 2025-09-30. FIGR currently screens at market cap $6.61B and trailing P/E 36.5.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
FIGR currently screens at market cap $6.61B and trailing P/E 36.5. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the FIGR and REGN stock pages for the full models.
Not investment advice.